Triple-B Study;Carboplatin-cyclophosphamide Versus Paclitaxel With or Without Atezolizumab as First-line Treatment in Advanced Triple Negative Breast Cancer

NCT01898117 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

304

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Carbo/cyclo
DRUG: Carbo/cyclo + atezolizumab
DRUG: Paclitaxel
DRUG: Paclitaxel + Atezolizumab

Sponsor

The Netherlands Cancer Institute

Collaborators

[object Object]
[object Object]